LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises
LONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises
Read moreLONDON MARKET PRE-OPEN: Barclays, AstraZeneca post sharp profit rises
Read more* Q1 total sales $7.32 bln, core EPS $1.63 beat forecasts* Maintains 2021 outlook; vaccine, Alexion impact excluded* Says on track to deliver 200 million doses a month* Shares jump as much as 4% after results beat forecasts* Oxford vaccine a drag on ...
Read more* Q1 total sales $7.32 bln, core EPS $1.63 beat forecasts* Maintains 2021 outlook; vaccine, Alexion impact excluded* Says on track to deliver 200 million doses a month* Shares jump as much as 4% after results beat forecasts (Recasts, adds quotes, up...
Read more* Q1 total sales $7.32 bln, core EPS $1.63 beat forecasts* CEO anticipates performance acceleration in H2* Maintains 2021 outlook; vaccine, Alexion impact excluded* Says ramping up vaccine supplies* Shares jump 4% after results beat forecasts (Adds ...
Read more* Q1 total sales $7.32 bln, core EPS $1.63 beat forecasts* CEO anticipates performance acceleration in H2* Maintains 2021 outlook; vaccine, Alexion impact excluded* Says ramping up vaccine supplies* Shares jump 3% after results beat forecasts (Adds ...
Read more* Q1 total sales $7.32 bln, core EPS $1.63 beat forecasts* CEO anticipates performance acceleration in H2* Maintains 2021 outlook; vaccine, Alexion impact excluded* Says ramping up vaccine supplies* Shares jump 2% in early trading (Writes through wi...
Read more(Adds details on earnings, analyst expectations, executive comment)April 30 (Reuters) - AstraZeneca said on Friday its COVID-19 vaccine contributed $275 million in sales and shaved off three cents per share from its first-quarter earnings, as the...
Read moreApril 30 (Reuters) - AstraZeneca said on Friday it expected higher sales in the second half of the year, as it reported first-quarter profit and sales ahead of analysts' average expectations, including $275 million in COVID-19 vaccine sales.(Repo...
Read more(Sharecast News) - AstraZeneca said it expected performance to accelerate as the drugs company reported "robust" revenue growth for the first quarter.
Read moreBy John MillerZURICH, April 29 (Reuters) - Denmark's top health official said on Thursday "the only ethical, correct decision" for some countries facing COVID-19 crises is to continue giving AstraZeneca's vaccine, though his nation halted use over...
Read more(Updates with more details, background)By Asif ShahzadISLAMABAD, April 29 (Reuters) - Pakistan has purchased 13 million doses of COVID-19 vaccine from three Chinese companies, its health minister told Reuters on Thursday.Faisal Sultan said Pakistan...
Read moreISLAMABAD, April 29 (Reuters) - Pakistan has purchased 13 million doses of COVID-19 vaccine from three Chinese companies, its health minister told Reuters on Thursday.Faisal Sultan said Pakistan had procured the vaccine from Sinopharm, CanSinoBio ...
Read moreBy Manas MishraApril 29 (Reuters) - Total global spending on COVID-19 vaccines is projected to reach $157 billion by 2025, driven by mass vaccination programs underway and "booster shots" expected every two years, according to a report by U.S. hea...
Read moreWASHINGTON, April 28 (Reuters) - The United States is sending supplies worth more than $100 million in the coming days to India to help it fight a surge of COVID-19 cases, the White House said on Wednesday. (Reporting by Eric Beech; Editing by Mo...
Read more(Adds talks aimed at financing Cuban vaccines)BUENOS AIRES, April 28 (Reuters) - Argentina's government said on Wednesday that it met with representatives of drugmaker AstraZeneca Plc to ask about "difficulties" in the production of its COVID-19 v...
Read more